Search

Riching, Andrew S, Etienne Danis, Yuanbiao Zhao, Yingqiong Cao, Congwu Chi, Rushita A Bagchi, Brianna J Klein, et al. 2021. “Suppression of Canonical TGF-β Signaling Enables GATA4 to Interact With H3K27me3 Demethylase JMJD3 to Promote Cardiomyogenesis.”. Journal of Molecular and Cellular Cardiology 153: 44-59.

Del Favero, Giorgia, Alois Bonifacio, Teisha J Rowland, Shanshan Gao, Kunhua Song, Valter Sergo, Eric D Adler, Luisa Mestroni, Orfeo Sbaizero, and Matthew R G Taylor. 2020. “Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and HiPSC-Derived Cardiomyocytes.”. Journal of Clinical Medicine 9 (8).

Han, Ke-Jun, Zhiping Wu, Chad G Pearson, Junmin Peng, Kunhua Song, and Chang-Wei Liu. 2019. “Deubiquitylase USP9X Maintains Centriolar Satellite Integrity by Stabilizing Pericentriolar Material 1 Protein.”. Journal of Cell Science 132 (2).

Riching, Andrew S, Yuanbiao Zhao, Yingqiong Cao, Pilar Londono, Hongyan Xu, and Kunhua Song. 2018. “Suppression of Pro-Fibrotic Signaling Potentiates Factor-Mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes.”. Journal of Visualized Experiments : JoVE, no. 136.

Zhou, Huanyu, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E Dickson, Kunhua Song, Wenduo Ye, Min S Kim, et al. 2017. “ZNF281 Enhances Cardiac Reprogramming by Modulating Cardiac and Inflammatory Gene Expression.”. Genes & Development 31 (17): 1770-83.

Zhao, Yuanbiao, Pilar Londono, Yingqiong Cao, Emily J Sharpe, Catherine Proenza, Rebecca O’Rourke, Kenneth L Jones, et al. 2015. “High-Efficiency Reprogramming of Fibroblasts into Cardiomyocytes Requires Suppression of Pro-Fibrotic Signalling.”. Nature Communications 6: 8243.

Sharp, TE., A. Scarborough, Z. Li, DJ. Polhemus, H. Hidalgo, JD. Schumacher, TR. Matsuura, et al. 2022. “Novel Gottingen Miniswine Model of Heart Failure With Preserved Ejection Fraction Integrating Multiple Comorbidities”. JACC: Basic to Translational Science.

Isaacson, SH, RA Hauser, R Pahwa, D Gray, and S Duvvuri. 2023. “Dopamine Agonists in Parkinson’s Disease: Impact of D1-Like or D2-Like Dopamine Receptor Subtype Selectivity and Avenues for Future Treatment. 2023 Jul 7;9:100212. Doi: 10.1016/J.prdoa.2023.100212. ECollection 2023. PMID: 37497384”. Clin Park Relat Disord.

Jenner, P, A Mori, SD Aradi, and RA Hauser. 2021. “Istradefylline - a First Generation Adenosine A2A antagonist for the Treatment of Parkinson’s Disease. Expert Rev Neurother 2021;21:317-333.”. Expert Rev Neurother.

“Expanding Phenotype With Severe Midline Brain Anomalies and Missense Variant Supports a Causal Role for FOXA2 in 20p11.2 Deletion Syndrome. American Journal of Medical Genetics. Part A, 179(9), 1783–1790.”. 2019. American Journal of Medical Genetics.